These data demonstrate the comparable and significant effects of the KCF18 and SEM18 peptides on inhibiting endotoxemia-induced upregulation of TNF-α and IL-1β in mouse plasma. The gene discussed is IL1B; the disease is serum lipopolysaccharide activity.